Our Research
The focus of our research is developing viral vector-based gene replacement strategies for the treatment of inherited ocular disease.
Play Video
Meet Dr. Boye
Dr. Shannon E. Boye received her B.S. in marine biology with a minor in chemistry from Fairleigh Dickinson University in 2001. She graduated with a Ph.D. in Neuroscience from the University of Florida in 2006. Her thesis work involved developing viral vectors for the treatment of retinal disease, specifically GUCY2D Leber Congenital Amaurosis (LCA1).
Recent Lab News
Dr. Calabro Receives NIH Pediatric Loan Repayment…
Congratulations to Dr. Kaitlyn Calabro for her receipt of the competitive NIH Pediatric Loan Repayment Program award! Kait’s award will relieve the…
Durham biotech company working on a therapy for…
Shannon Boye, a scientist at the University of Florida, is the co-founder of a new gene-therapy startup in Durham called Atsena Therapeutics. The…
Dr. Boye to Give Opening Presentation at VISIONS…
Participants of Virtual VISIONS 2020 are invited to join live for the opening presentation, “Mission Possible! What’s Next for Gene Therapy…
